Trusted Sources

FUZEON Questions ? Need a second opinion? Ask Our Health Experts!

Type your question here

 letters left

FUZEON Safety Reports

Total FUZEON reports: 140. FUZEON FDA safety alerts: No. Reported deaths: 9    Reported hospitalizations: 63. Read More Here.

< Previous  Showing 101-140 of 140

Consumer or non-health professional from UNITED STATES reported FUZEON problem on Aug 18, 2004. Male patient, 60 years of age, weighting 177.9 lb, was diagnosed with hiv infection, sciatica and was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, blood glucose abnormal, blood pressure increased, blood triglycerides increased, clumsiness, constipation, dehydration, depression, dry mouth. FUZEON dosage: unknown. During the same period patient was treated with GABAPENTIN, TRICOR, GLYBURIDE, ZIAGEN, REYATAZ, GLUCOPHAGE, CELEBREX, PRAVACHOL. Patient was hospitalized. Patient recovered.

FUZEON problem was reported by a Consumer or non-health professional from FRANCE on Feb 09, 2006. Female patient, 44 years of age, weighting 121.3 lb, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: dyspnoea, eosinophilia, pruritus. FUZEON dosage: unknown. During the same period patient was treated with TIPRANAVIR, NORVIR. Patient was hospitalized. Patient recovered.

Health Professional from CANADA reported FUZEON problem on Aug 29, 2005. Male patient, 39 years of age, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: abdominal rigidity, anorexia, eructation, fatigue, feeling hot, headache, injection site mass, injection site reaction. FUZEON dosage: unknown. During the same period patient was treated with COMBIVIR, NORVIR, ZITHROMAX, TIPRANAVIR, VIDEX. Patient recovered.

FUZEON problem was reported by a Consumer or non-health professional from UNITED STATES on May 18, 2006. Male patient, 49 years of age, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: cat scratch disease. FUZEON dosage: unknown. During the same period patient was treated with STEROIDS NOS, COMBIVIR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FUZEON problem on May 17, 2006. Female patient, 33 years of age, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: caesarean section, nausea, viral load increased, vomiting. FUZEON dosage: unknown. During the same period patient was treated with VIRACEPT, EPIVIR, VIRAMUNE, VIREAD, NORVIR, FOSAMPRENAVIR, COMBIVIR. Patient was hospitalized. Patient recovered.

FUZEON problem was reported by a Physician from UNITED STATES on Aug 18, 2004. Male patient, 60 years of age, weighting 177.9 lb, was diagnosed with hiv infection, sciatica and was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: anger, blood cholesterol increased, blood glucose abnormal, blood glucose decreased, blood glucose increased, blood pressure increased, blood triglycerides increased, clumsiness, constipation. FUZEON dosage: unknown. During the same period patient was treated with GABAPENTIN, TRICOR, GLYBURIDE, ZIAGEN, REYATAZ, GLUCOPHAGE, CELEBREX, PRAVACHOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FUZEON problem on May 24, 2006. Male patient was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: ankle fracture, fall. FUZEON dosage: unknown. Patient was hospitalized. Patient recovered.

FUZEON problem was reported by a Physician from UNITED STATES on May 26, 2006. Female patient was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. FUZEON dosage: unknown. During the same period patient was treated with APTIVUS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FUZEON problem on May 24, 2006. Female patient, 22 years of age, was diagnosed with hiv infection and was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: abortion missed. FUZEON dosage: unknown. During the same period patient was treated with VIRACEPT, BIOVIR, VITAMIN NOS, FERROUS SULPHATE. Patient recovered.

FUZEON problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 24, 2006. Male patient, 39 years of age, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, chronic obstructive pulmonary disease, injection site bruising, injection site haematoma, pneumonia. FUZEON dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FUZEON problem on June 05, 2006. Female patient was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: abdominal distension, erythema, fluid retention, hypoglycaemia, injection site urticaria, insulin resistance, myasthenia gravis. FUZEON dosage: unknown. Patient recovered.

FUZEON problem was reported by a Consumer or non-health professional from UNITED STATES on June 08, 2006. Male patient, 52 years of age, was diagnosed with depression and was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: dementia, injection site abscess, injection site mass. FUZEON dosage: unknown. During the same period patient was treated with TRUVADA, KALETRA, LEXIVA, REMERON, WELLBUTRIN, CARBIDOPA AND LEVODOPA, AMPHETAMINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FUZEON problem on June 08, 2006. Male patient, 51 years of age, was diagnosed with depression and was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: abscess, dementia, injection site reaction. FUZEON dosage: unknown. During the same period patient was treated with TRUVADA, KALETRA, LEXIVA, REMERON, WELLBUTRIN, CARBIDOPA AND LEVODOPA, AMPHETAMINE. Patient recovered.

FUZEON problem was reported by a Physician from FRANCE on Apr 24, 2006. Male patient, 41 years of age, weighting 132.3 lb, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: encephalopathy. FUZEON dosage: unknown. During the same period patient was treated with NORVIR, KALETRA, TELZIR, TRIZIVIR. Patient was hospitalized and became disabled. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FUZEON problem on June 30, 2006. Male patient was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: anaemia. FUZEON dosage: unknown. Patient was hospitalized. Patient recovered.

FUZEON problem was reported by a Consumer or non-health professional from FRANCE on July 10, 2006. Male patient, 45 years of age, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: b-cell lymphoma. FUZEON dosage: unknown. During the same period patient was treated with VIREAD, NORVIR, VIDEX. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FUZEON problem on July 13, 2006. Male patient was diagnosed with blood pressure and was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: thrombosis. FUZEON dosage: unknown. During the same period patient was treated with KALETRA. Patient recovered.

FUZEON problem was reported by a Physician from UNITED STATES on June 08, 2006. Male patient, 51 years of age, weighting 282.0 lb, was diagnosed with depression and was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: abscess, dementia, injection site discolouration, injection site pain, injection site reaction. FUZEON dosage: unknown. During the same period patient was treated with TRUVADA, KALETRA, LEXIVA, REMERON, WELLBUTRIN, CARBIDOPA AND LEVODOPA, AMPHETAMINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FUZEON problem on July 24, 2006. Male patient, 20 years of age, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: gastric disorder. FUZEON dosage: unknown. Patient was hospitalized. Patient recovered.

FUZEON problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2006. Male patient was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: leukaemia. FUZEON dosage: unknown. During the same period patient was treated with CYCLOVIR, EPZICOM, SEPTRA. Patient recovered.

Consumer or non-health professional from FRANCE reported FUZEON problem on Aug 08, 2006. Male patient, 44 years of age, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: hepatitis cholestatic, hepatosplenomegaly, hyperbilirubinaemia. FUZEON dosage: unknown. During the same period patient was treated with TIPRANAVIR, COMBIVIR, NORVIR. Patient was hospitalized. Patient recovered.

FUZEON problem was reported by a Physician from BRAZIL on Aug 23, 2006. Male patient, 40 years of age, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: asthenia, blood creatine phosphokinase increased, blood lactic acid increased, muscular weakness, transaminases increased. FUZEON dosage: unknown. During the same period patient was treated with TENOFOVIR, LAMIVUDINE, AMPRENAVIR, EFAVIRENZ, SAQUINAVIR. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FUZEON problem on Aug 10, 2003. Male patient, 56 years of age, weighting 160.1 lb, was diagnosed with hiv infection and was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: arthropod bite, blood hiv rna increased, injection site reaction, nausea, pneumonia. FUZEON dosage: unknown. During the same period patient was treated with ATAZANAVIR, VIREAD, VIDEX, COMBIVIR. Patient was hospitalized. Patient recovered.

FUZEON problem was reported by a Physician from SWITZERLAND on Sept 06, 2006. Male patient, 19 years of age, was diagnosed with hiv infection and was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: injection site haemorrhage, muscle haemorrhage. FUZEON dosage: unknown. During the same period patient was treated with REYATAZ, VIDEX. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported FUZEON problem on Sept 05, 2006. Male patient, 38 years of age, weighting 191.8 lb, was diagnosed with hiv infection and was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, chills, pyrexia. FUZEON dosage: unknown. During the same period patient was treated with TRIZIVIR, VIREAD, NORVIR. Patient recovered.

FUZEON problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 23, 2005. Male patient, 48 years of age, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: anaemia, cough, injection site pain, malaise, pyrexia, skin hypertrophy, weight decreased. FUZEON dosage: unknown. During the same period patient was treated with APTIVUS, NORVIR, COMBIVIR, VIREAD. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported FUZEON problem on Dec 22, 2006. Male patient, 52 years of age, weighting 172.0 lb, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: arthralgia, renal failure acute. FUZEON dosage: unknown. During the same period patient was treated with TRUVADA, NORVIR, KALETRA. Patient was hospitalized. Patient recovered.

FUZEON problem was reported by a Physician from BRAZIL on Jan 08, 2007. Female patient, 56 years of age, weighting 132.3 lb, was diagnosed with hiv infection and was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: hepatic failure, renal failure. FUZEON dosage: unknown. During the same period patient was treated with TENOFOVIR, LAMIVUDINE, EFAVIRENZ. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported FUZEON problem on Jan 11, 2007. Male patient, 47 years of age, weighting 160.9 lb, was diagnosed with hiv infection and was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: angioedema, hypersensitivity, malaise, palpitations, urticaria. FUZEON dosage: unknown. During the same period patient was treated with TRUVADA. Patient was hospitalized. Patient recovered.

FUZEON problem was reported by a Consumer or non-health professional from FRANCE on Jan 19, 2007. Male patient, 40 years of age, weighting 149.9 lb, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, cytolytic hepatitis, folliculitis, molluscum contagiosum, rhabdomyolysis. FUZEON dosage: unknown. During the same period patient was treated with KIVEXA, VIDEX, PREZISTA, NORVIR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FUZEON problem on Jan 26, 2007. Male patient, 44 years of age, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: erosive oesophagitis, ulcer haemorrhage. FUZEON dosage: unknown. Patient was hospitalized. Patient recovered.

FUZEON problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 31, 2007. Male patient, 57 years of age, was diagnosed with hiv infection and was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: anaemia, blood cholesterol abnormal, injection site reaction, lipodystrophy acquired, necrosis, obstruction, thrombosis, urticaria. FUZEON dosage: unknown. During the same period patient was treated with PROTEASE INHIBITOR. Patient recovered.

Consumer or non-health professional from FRANCE reported FUZEON problem on Feb 06, 2007. Male patient, 58 years of age, weighting 180.8 lb, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. FUZEON dosage: unknown. During the same period patient was treated with APTIVUS, TRUVADA, NORVIR. Patient was hospitalized. Patient recovered.

FUZEON problem was reported by a Consumer or non-health professional from MEXICO on Feb 14, 2007. Male patient, 51 years of age, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: asthenia. FUZEON dosage: unknown. During the same period patient was treated with TIPRANAVIR, LAMIVUDINE. Patient died.

Consumer or non-health professional from FRANCE reported FUZEON problem on Feb 15, 2007. Male patient, 52 years of age, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: coronary artery disease. FUZEON dosage: unknown. During the same period patient was treated with PREZISTA, KIVEXA, NORVIR. Patient was hospitalized and became disabled. Patient recovered.

FUZEON problem was reported by a Physician from MEXICO on Feb 21, 2007. Male patient, 51 years of age, was diagnosed with hiv infection and was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: asthenia, disease progression. FUZEON dosage: unknown. During the same period patient was treated with TIPRANAVIR, LAMIVUDINE. Patient died on 10/04/2006.

Consumer or non-health professional from FRANCE reported FUZEON problem on Feb 22, 2007. Male patient, 42 years of age, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: blood methaemoglobin present, cholestasis, cytolytic hepatitis, dyspnoea, hyperlipidaemia, lactic acidosis, pancreatitis. FUZEON dosage: unknown. During the same period patient was treated with TMC, AZADOSE, EPIVIR, NORVIR, VIDEX, LASIX, CORTANCYL, VALACYCLOVIR. Patient was hospitalized. Patient recovered.

FUZEON problem was reported by a Physician from UNITED STATES on Mar 12, 2007. Female patient, 73 years of age, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: eaton-lambert syndrome. FUZEON dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported FUZEON problem on Mar 15, 2007. Male patient was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, asthenia, decreased appetite, depression, dysgeusia, glossodynia, insomnia, lymphadenopathy, sinus disorder. FUZEON dosage: unknown. During the same period patient was treated with ACYCLOVIR, PREDNISONE, VALTREX. Patient was hospitalized. Patient recovered.

FUZEON problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 16, 2007. Female patient, 31 years of age, was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, placental infarction, umbilical cord abnormality. FUZEON dosage: unknown. During the same period patient was treated with VALGANCICLOVIR, DIDANOSINE, LAMIVUDINE, REYATAZ, RITONAVIR. Patient died.

< Previous  Showing 101-140 of 140